PTC Therapeutics’ $211M Bid Wins Bankruptcy Auction for Sangamo Gene Therapy
PTC Therapeutics is expanding its prospects in rare disease, winning a bankruptcy auction for a Sangamo Therapeutics gene therapy that’s already on a fast path to regulatory review by the FDA. The...









